🇺🇸 FDA
Pipeline program

zelicapavir

EDP 938-203

Phase 2 small_molecule active

Quick answer

zelicapavir for RSV Infection is a Phase 2 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ENANTA PHARMACEUTICALS INC
Indication
RSV Infection
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials